Patents by Inventor Heleen SCHEERENS

Heleen SCHEERENS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating asthma using an IL-13 antibody
    Patent number: 11226341
    Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: January 18, 2022
    Assignee: Genentech, Inc.
    Inventors: Joseph R. Arron, Richard W. Erickson, Michelle Freemer, Meredith Hazen, Guiquan Jia, John G. Matthews, Wendy Putnam, Heleen Scheerens, Yanan Zheng
  • DIAGNOSIS AND TREATMENTS RELATING TO TH2 INHIBITION
    Publication number: 20190120854
    Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
    Type: Application
    Filed: May 29, 2018
    Publication date: April 25, 2019
    Inventors: Joseph R. Arron, Richard W. Erickson, Michelle Freemer, Meredith Hazen, Guiquan Jia, John G. Matthews, Wendy Putnam, Heleen Scheerens, Yanan Zheng
  • METHODS OF DETECTING AND QUANTIFYING IL-13 AND USES IN DIAGNOSING AND TREATING TH2-ASSOCIATED DISEASES
    Publication number: 20180356429
    Abstract: Methods of detecting and quantifying IL-13 are provided. Also provided are methods of diagnosing, selecting and identifying patients with Th2-associated diseases (Type 2-associated diseases) for treatment with certain therapeutic agents that are Th2 pathway inhibitors (Type 2 pathway inhibitors).
    Type: Application
    Filed: September 11, 2017
    Publication date: December 13, 2018
    Applicants: Genentech, Inc., Hoffmann-La Roche Inc.
    Inventors: Alyssa Morimoto, Kun Peng, Heleen Scheerens, Fang Cai, Hans Hornauer
  • Diagnosis and treatments relating to TH2 inhibition
    Patent number: 9995755
    Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: June 12, 2018
    Assignee: GENENTECH, INC.
    Inventors: Joseph R. Arron, Richard W. Erickson, Michelle Freemer, Meredith Hazen, Guiquan Jia, John G. Matthews, Wendy Putnam, Heleen Scheerens, Yanan Zheng
  • Diagnosis and treatments relating to TH2 inhibition
    Patent number: 9684000
    Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: June 20, 2017
    Assignee: GENENTECH, INC.
    Inventors: Joseph R. Arron, Richard W. Erickson, Michelle Freemer, Meredith Hazen, Guiquan Jia, John G. Matthews, Wendy Putnam, Heleen Scheerens, Yanan Zheng
  • Bruton's tyrosine kinase activity probe and method of using
    Patent number: 8987233
    Abstract: Described herein are probes for Bruton's tyrosine kinase (Btk). Such probes are used to characterize and develop Btk-selective inhibitors intended for therapeutic use.
    Type: Grant
    Filed: November 5, 2007
    Date of Patent: March 24, 2015
    Assignee: Pharmacyclics, Inc.
    Inventors: Zhengying Pan, Shyr Jiann Li, Heleen Scheerens, Lee Honigberg, Erik Verner
  • DIAGNOSIS AND TREATMENTS RELATING TO TH2 INHIBITION
    Publication number: 20140044702
    Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
    Type: Application
    Filed: September 9, 2013
    Publication date: February 13, 2014
    Applicant: Genentech, Inc.
    Inventors: Joseph R. Arron, Richard W. Erickson, Michelle Freemer, Meredith Hazen, Guiquan Jia, John G. Matthews, Wendy Putnam, Heleen Scheerens, Yanan Zheng
  • DIAGNOSIS AND TREATMENTS RELATING TO TH2 INHIBITION
    Publication number: 20140044645
    Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
    Type: Application
    Filed: September 9, 2013
    Publication date: February 13, 2014
    Applicant: Genentech, Inc.
    Inventors: Joseph R. Arron, Richard W. Erickson, Michelle Freemer, Meredith Hazen, Guiquan Jia, John G. Matthews, Wendy Putnam, Heleen Scheerens, Yanan Zheng
  • ANTI-IGE ANTIBODIES AND METHODS USING SAME
    Publication number: 20130243750
    Abstract: This invention provides anti-IgE antibodies that bind to the M1? segment of a human IgE and their use in treating and preventing IgE-mediated disorders, as well as kits comprising the anti-IgE antibodies.
    Type: Application
    Filed: January 30, 2013
    Publication date: September 19, 2013
    Applicant: Genentech, Inc.
    Inventors: Heleen Scheerens, Jeffrey Mark Harris, John Matthews, Wendy Sue Putnam, X. Charlene Liao
  • DIAGNOSIS AND TREATMENTS RELATING TO TH2 INHIBITION
    Publication number: 20120156194
    Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
    Type: Application
    Filed: December 16, 2011
    Publication date: June 21, 2012
    Applicant: Genentech, Inc.
    Inventors: Joseph R. Arron, Richard W. Erickson, Michelle Freemer, Meredith Hazen, Guiquan Jia, John G. Matthews, Wendy Putnam, Heleen Scheerens, Yanan Zheng
  • BRUTON'S TYROSINE KINASE ACTIVITY PROBE AND METHOD OF USING
    Publication number: 20080214501
    Abstract: Described herein are probes for Bruton's tyrosine kinase (Btk). Such probes are used to characterize and develop Btk-selective inhibitors intended for therapeutic use.
    Type: Application
    Filed: November 5, 2007
    Publication date: September 4, 2008
    Applicant: PHARMACYCLICS, INC.
    Inventors: Zhengying PAN, Shyr Jiann Li, Heleen SCHEERENS, Lee HONIGBERG, Erik VERNER